The Oncology Institute, Inc.TOINASDAQ
Loading
Operating Cash Flow Growth AcceleratingAccelerating
Percentile Rank92
3Y CAGR+58.8%
5Y CAGR-1.9%
Year-over-Year Change
Year-over-year operating cash flow growth rate
3Y CAGR
+58.8%/yr
Quarterly compound
5Y CAGR
-1.9%/yr
Recent acceleration
Percentile
P92
Near historical high
vs 5Y Ago
0.9x
Contraction
Streak
3 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | 125.60% |
| Q3 2025 | -23.80% |
| Q2 2025 | -104.53% |
| Q1 2025 | -219.16% |
| Q4 2024 | 411.11% |
| Q3 2024 | 105.23% |
| Q2 2024 | 1.40% |
| Q1 2024 | -307.99% |
| Q4 2023 | 53.15% |
| Q3 2023 | 4.04% |
| Q2 2023 | 43.96% |
| Q1 2023 | -10.40% |
| Q4 2022 | 31.38% |
| Q3 2022 | -96.54% |
| Q2 2022 | 38.88% |
| Q1 2022 | 27.23% |
| Q4 2021 | -771.03% |
| Q3 2021 | 62.43% |
| Q2 2021 | -1636.64% |
| Q1 2021 | -54.01% |
| Q4 2020 | 138.52% |
| Q3 2020 | 56.62% |
| Q2 2020 | -20899.44% |
| Q1 2020 | 0.00% |
| Q4 2018 | 0.00% |